OxyContin manufacturer Purdue Pharma generated more than $10 billion since 2008 for the Sackler family members who own the company, a report said
OxyContin manufacturer Purdue Pharma LP generated more than $10 billion since 2008 for the Sackler family members who own the company, according to a report that will influence the debate among state and local governments over how much of that money should be returned.
The report, written by Purdue adviser AlixPartners LLP and filed in a New York bankruptcy court Monday, is the most thorough accounting yet of dividends collected by the controlling Sackler family during years in which opioid consumption grew into a nationwide...
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Purdue Pharma’s foreign affiliate now selling overdose cureThe gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on...
Consulte Mais informação »
Purdue Pharma’s foreign affiliate now selling overdose cureThe gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on...
Consulte Mais informação »
Sackler-owned opioid maker goes global with OD treatmentA Purdue Pharma affiliate has expanded abroad, selling addictive opioids using some of the tactics that made its owners among the world's richest. From Europe to Australia, Mundipharma also aims to dominate the opioid overdose treatment market.
Consulte Mais informação »